Zheng, Ju-ShengSharp, Stephen JImamura, FumiakiKoulman, AlbertSchulze, Matthias BYe, ZhengGriffin, JulesGuevara, MarcelaHuerta, José MaríaKröger, JanineSluijs, IvonneAgudo, AntonioBarricarte, AurelioBoeing, HeinerColorado-Yohar, SandraDow, CourtneyDorronsoro, MirenDinesen, Pia TFagherazzi, GuyFranks, Paul WFeskens, Edith J MKühn, TilmanKatzke, Verena AndreaKey, Timothy JKhaw, Kay-Teede Magistris, Maria SantucciMancini, Francesca RomanaMolina-Portillo, ElenaNilsson, Peter MOlsen, AnjaOvervad, KimPalli, DomenicoQuirós, Jose RamónRolandsson, OlovRicceri, FulvioSpijkerman, Annemieke M WSlimani, NadiaTagliabue, GiovannaTjonneland, AnneTumino, Rosariovan der Schouw, Yvonne TLangenberg, ClaudiaRiboli, ElioForouhi, Nita GWareham, Nicholas J2018-03-082018-03-082017-11-17Association between plasma phospholipid saturated fatty acids and metabolic markers of lipid, hepatic, inflammation and glycaemic pathways in eight European countries: a cross-sectional analysis in the EPIC-InterAct study. 2017, 15 (1):203 BMC Med1741-70152914589210.1186/s12916-017-0968-4http://hdl.handle.net/10029/621549Accumulating evidence suggests that individual circulating saturated fatty acids (SFAs) are heterogeneous in their associations with cardio-metabolic diseases, but evidence about associations of SFAs with metabolic markers of different pathogenic pathways is limited. We aimed to examine the associations between plasma phospholipid SFAs and the metabolic markers of lipid, hepatic, glycaemic and inflammation pathways.enArchived with thanks to BMC medicineAssociation between plasma phospholipid saturated fatty acids and metabolic markers of lipid, hepatic, inflammation and glycaemic pathways in eight European countries: a cross-sectional analysis in the EPIC-InterAct study.ArticleBMC Med 2017; 15(1):203